China News Service, Nanjing, June 5th (Xu Shanshan) "These epidemics were very beautiful. Although the beginning was very difficult, they ended perfectly." On the 5th, Qiu Haibo, a member of the expert group of the Central Steering Group, was fighting the new crown pneumonia 139 days and nights later, he said when he arrived in Nanjing.
On January 19, Qiu Haibo received an order from the National Health Commission on his business trip, and he rushed to Wuhan to participate in epidemic prevention and treatment and guidance.
Meet the team that day. Zhang Xinshe
After "zeroing" severe cases in Wuhan, Qiu Haibo left Wuhan, where he had been fighting for 99 days, and went to Heilongjiang to continue fighting to guide the treatment of local new coronary pneumonia.
This way, he did not stop, from cold winter to early summer, from Jiangsu to Hubei, then to Heilongjiang and Jilin, went deep into the "red zone" of the war epidemic, and always struggled on the front line.
In Wuhan, Qiu Haibo will run three or four hospitals including Wuhan Jinyintan Hospital, Wuhan Pulmonary Hospital, and Wuhan University Central South Hospital within a day to patrol critical cases and give targeted diagnosis and treatment recommendations.
"During this process, the diagnosis and treatment plan for patients is becoming more and more mature." Qiu Haibo said with emotion that he referred to the "New Coronavirus Pneumonia Treatment Plan (Trial Version 7)" published on March 4.
Going through Hubei, Heilongjiang, and Jilin, Qiu Haibo said, "The accumulation of early experience has made the later treatment more standardized and positive, and the checkpoint is advanced, so the success rate of patient treatment is much greater than that of the early stage."
"We have brought the experience of anti-epidemic disease in Wuhan, Hubei to the northeast, and made targeted and personalized treatment strategies based on the characteristics of the cases in Heilongjiang and Jilin." Qiu Haibo said that the cases in Heilongjiang and Jilin are different from the cases in Hubei.
He said that in terms of gene sequencing, most of the cases in Heilongjiang and Jilin are imported related cases, and the virus is completely consistent with the imported case, and is not the same as the virus of the local case in Hubei.
From a clinical point of view, the incubation period of confirmed cases in Heilongjiang and Jilin provinces is longer, and the clinical symptoms are not typical. The clinical feature of the Wuhan case is that the patient has multiple organ involvement, not only lung involvement, but also damage to the heart muscle, kidneys, and intestines.
Qiu Haibo cherished the 139-day anti-epidemic experience. He said, "This year's epidemic has taught us a lesson. This lesson is very expensive and makes everyone realize the importance of building a strong public health system."
"Further strengthening the public health system is a future-oriented and proactive measure. I believe that with such a measure, we will be able to deal with any situation in the future," Qiu Haibo said. (Finish)